|
|
Article: DIAG, IPS and KNOL Update the Investment Community in All-New Interviews With WallSt.net.
- Article from:
- PR Newswire
- Article date:
- March 20, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK, March 20 /PRNewswire/ -- On March 12, WallSt.net featured an all-new interview profiling DiaGenic ASA . Conducting the interview on behalf of the company was its Chairman, Haakon Sateroy, and the company's Chief Executive Officer, Erik Christensen. Interview highlights include detailed discussions on the following topics:
-- "rapid" development of the company's target markets, and the
opportunity for the company's technology
-- Reasons the company has a competitive edge in its target markets
-- Recently validated prototypes for diagnosis of both breast cancer and
Alzheimer's Disease, and what it means for the company's continued
...